Works matching IS 10538569 AND DT 2023 AND VI 32 AND IP 3
Results: 15
Corrigendum to "Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden – a population‐based register study".
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 395, doi. 10.1002/pds.5588
- Publication type:
- Article
Federated analyses of multiple data sources in drug safety studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 279, doi. 10.1002/pds.5587
- By:
- Publication type:
- Article
Pharmacogenetics of warfarin and healthcare costs – Real‐world data analysis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 382, doi. 10.1002/pds.5585
- By:
- Publication type:
- Article
Identification of polypharmacy patterns in new‐users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 366, doi. 10.1002/pds.5583
- By:
- Publication type:
- Article
Recommendations on the calculation of confidence intervals for sequence symmetry analyses.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 392, doi. 10.1002/pds.5578
- By:
- Publication type:
- Article
A review of pregnancy and lactation postmarketing studies required by the FDA.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 287, doi. 10.1002/pds.5572
- By:
- Publication type:
- Article
A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 352, doi. 10.1002/pds.5567
- By:
- Publication type:
- Article
Social media for early characterization of pandemic symptoms: A qualitative analysis of patient‐reported COVID‐19 experiences.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 341, doi. 10.1002/pds.5564
- By:
- Publication type:
- Article
Imputing missing covariates in time‐to‐event analysis within distributed research networks: A simulation study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 330, doi. 10.1002/pds.5563
- By:
- Publication type:
- Article
Healthcare system engagement and algorithm‐identified cancer incidence following initiation of a new medication.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 321, doi. 10.1002/pds.5556
- By:
- Publication type:
- Article
More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 387, doi. 10.1002/pds.5555
- By:
- Publication type:
- Article
A new analytic tool for assessing the impact of the US Food and Drug Administration regulatory actions.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 298, doi. 10.1002/pds.5552
- By:
- Publication type:
- Article
Attention to risk information in direct‐to‐consumer prescription drug print ads: An eye‐tracking study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 312, doi. 10.1002/pds.5511
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 396, doi. 10.1002/pds.5458
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 1, doi. 10.1002/pds.5457
- Publication type:
- Article